{
  "resourceType": "ValueSet",
  "id": "oncology-MammaprintRiskScoreInterpretationVS",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p><b>BC MammaprintRiskScoreInterpretationVS ValueSet</b></p>\n<p>Intepretation of Mammaprint Recurrence Score</p>\n</div>"
  },
  "url": "http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-MammaprintRiskScoreInterpretationVS",
  "identifier": [
    {
      "system": "http://hl7.org/fhir/us/breastcancer",
      "value": "oncology.MammaprintRiskScoreInterpretationVS"
    }
  ],
  "name": "MammaprintRiskScoreInterpretationVS",
  "title": "BC MammaprintRiskScoreInterpretationVS ValueSet",
  "status": "draft",
  "publisher": "The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC)",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://standardhealthrecord.org"
        }
      ]
    }
  ],
  "date": "2018-05-02",
  "description": "Intepretation of Mammaprint Recurrence Score",
  "compose": {
    "include": [
      {
        "system": "http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-MammaprintRiskScoreInterpretationCS",
        "concept": [
          {
            "code": "low_risk",
            "display": "Score between 0.0 and +1.0, meaning a patient has on average a 10% chance that her cancer will recur within 10 years without any additional adjuvant treatment, either hormonal therapy or chemotherapy."
          },
          {
            "code": "high_risk",
            "display": "Score between -1.0 and 0.0, meaning a patient has a 29% chance that her cancer will recur within 10 years without any additional adjuvant treatment, either hormonal therapy or chemotherapy."
          }
        ]
      }
    ]
  }
}